NFE2L2 and hepatocellular carcinoma: Accordingly, the stable knockdown of KEAP1 was also found to enhance while NRF2 silencing repressed the expression of TKT in HCC cells, wherein this enzyme promoted NADPH synthesis, tumor growth, metastasis formation and sorafenib resistance [154].